60 related articles for article (PubMed ID: 8343047)
1. The prognostic value of human chorionic gonadotropin expression in colorectal adenocarcinomas. An immunohistochemical study of 102 stage B2 and C2 nonmucinous adenocarcinomas.
Connelly JH; Johnston DA; Bruner JM
Arch Pathol Lab Med; 1993 Aug; 117(8):824-6. PubMed ID: 8343047
[TBL] [Abstract][Full Text] [Related]
2. Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma--immunohistochemistry and Western blot analysis.
Milićević ZT; Petković MZ; Drndarević NC; Pavlović MD; Todorović VN
Neoplasma; 2007; 54(1):37-45. PubMed ID: 17233550
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
5. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
6. The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival.
Tsamandas AC; Kardamakis D; Ravazoula P; Zolota V; Salakou S; Tepetes K; Kalogeropoulou C; Tsota I; Kourelis T; Makatsoris T; Karavias D; Scopa CD; Bonikos DS; Kalofonos HP; Petsas T
Strahlenther Onkol; 2004 Apr; 180(4):201-8. PubMed ID: 15057430
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.
Soliani P; Ziegler S; Romani A; Corcione L; Campanini N; Dell'Abate P; Del Rio P; Sianesi M
Oncol Rep; 2004 Jun; 11(6):1193-200. PubMed ID: 15138555
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CD44 expression in colorectal carcinomas.
Sökmen S; Lebe B; Sarioglu S; Füzün M; Terzi C; Küpelioglu A; Ellidokuz H
Anticancer Res; 2001; 21(6A):4121-6. PubMed ID: 11911305
[TBL] [Abstract][Full Text] [Related]
10. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
[TBL] [Abstract][Full Text] [Related]
11. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
[TBL] [Abstract][Full Text] [Related]
12. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
13. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
Zhang Hong
Clin Cancer Res; 1999 Dec; 5(12):4126-32. PubMed ID: 10632350
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms.
Bhatnagar J; Heroman W; Murphy M; Austin GE
Anticancer Res; 2002; 22(3):1849-57. PubMed ID: 12168881
[TBL] [Abstract][Full Text] [Related]
16. Low levels of insulin-like growth factor type 1 receptor expression at cancer cell membrane predict liver metastasis in Dukes' C human colorectal cancers.
Nakamura M; Miyamoto S; Maeda H; Zhang SC; Sangai T; Ishii G; Hasebe T; Endoh Y; Saito N; Asaka M; Ochiai A
Clin Cancer Res; 2004 Dec; 10(24):8434-41. PubMed ID: 15623623
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic and immunohistochemical study of small apparently "de novo" colorectal adenocarcinomas.
Hornick JL; Farraye FA; Odze RD
Am J Surg Pathol; 2007 Feb; 31(2):207-15. PubMed ID: 17255765
[TBL] [Abstract][Full Text] [Related]
18. [P53 protein in adenocarcinoma of the large intestine].
Paluszkiewicz P; Pawłowska-Wakowicz B; Cybulski M; Berbeć H
Wiad Lek; 1997; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas.
Komatsu K; Andoh A; Ishiguro S; Suzuki N; Hunai H; Kobune-Fujiwara Y; Kameyama M; Miyoshi J; Akedo H; Nakamura H
Clin Cancer Res; 2000 Jan; 6(1):172-7. PubMed ID: 10656447
[TBL] [Abstract][Full Text] [Related]
20. A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer.
Lundin M; Nordling S; Carpelan-Holmstrom M; Louhimo J; Alfthan H; Stenman UH; Haglund C
Anticancer Res; 2000; 20(6D):4949-51. PubMed ID: 11326644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
